02256 Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

0 Analyst Rating

Wall Street analysts forecast 02256 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 02256 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

0 Hold

0 Sell

Current: 0.000

Low

Averages

High

Current: 0.000

Low

Averages

High

No data

Valuation Metrics

The current forward P/E ratio for ABBISKO-B (02256.HK) is 316.59, compared to its 5-year average forward P/E of 68.56. For a more detailed relative valuation and DCF analysis to assess ABBISKO-B 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

68.56

Current PE

316.59

Overvalued PE

2589.74

Undervalued PE

-2452.62

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

24.43

Current EV/EBITDA

247.32

Overvalued EV/EBITDA

88.93

Undervalued EV/EBITDA

-40.07

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

294.28

Current PS

13.32

Overvalued PS

697.57

Undervalued PS

-109.00

Financials

Annual

Quarterly

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

02256 News & Events

Events Timeline

No data

News

8.5

01:04 AMYahoo Finance

PinnedAbbisko Therapeutics' NDA for Pimicotinib Accepted by FDA, Significant Tumor Treatment Improvement

8.5

01:56 AMPRnewswire

Abbisko Therapeutics' NDA for Pimicotinib Accepted by FDA, Promising Significant Tumor Treatment Improvements

6.5

2025-12-11aastocks

<Research>CMSI Forecasts Modest Economic Growth in the US Next Year; Hong Kong Stock Market to Transition Towards Earnings-Driven Performance

People Also Watch

Frequently Asked Questions

What is ABBISKO-B (02256) stock price today?

The current price of 02256 is 14.83 USD — it has increased 2.42 % in the last trading day.

What is ABBISKO-B (02256)'s business?

What is the price predicton of 02256 Stock?

Wall Street analysts forecast 02256 stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for 02256 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is ABBISKO-B (02256)'s revenue for the last quarter?

ABBISKO-B revenue for the last quarter amounts to NaN USD, decreased % YoY.

What is ABBISKO-B (02256)'s earnings per share (EPS) for the last quarter?

ABBISKO-B. EPS for the last quarter amounts to USD, decreased % YoY.

What changes have occurred in the market's expectations for ABBISKO-B (02256)'s fundamentals?

The market is revising No Change the revenue expectations for 02256 for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by %.

How many employees does ABBISKO-B (02256). have?

ABBISKO-B (02256) has 0 emplpoyees as of January 13 2026.

What is ABBISKO-B (02256) market cap?

Today 02256 has the market capitalization of 0.00 USD.